INFLIXIMAB
infliximab 120 mg/mL injection, 1 mL pen device
INFLIXIMAB (13056E)
13056E
Manner of administration:Injection
Restriction
Indication: Severe psoriatic arthritis
Treatment phase: Balance of supply (including switching formulation) where the full duration of treatment
available under a particular treatment phase was not requested in the preceding prescription
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $578.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Remsima SC | |||||